Press Release Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD) 7 May 2024
Press Release 4me Announces Global User Event ‘Connect 24’ – Showcasing Innovations in Service Management 7 May 2024
Press Release KKR and Marriott International to Launch Midscale Hospitality Segment in Japan with Four Points Express by Sheraton 7 May 2024
Press Release Innate Pharma Announces Conference Call and Webcast for Q1 2024 Business Update 7 May 2024
Press Release Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries 7 May 2024
Press Release Newsome Melton Secures $9 Million Jury Verdict in Tennis Pro Kylie McKenzie’s Case Against USTA 7 May 2024
